『Markets Hunter - With Hunter Gaylor』のカバーアート

Markets Hunter - With Hunter Gaylor

Markets Hunter - With Hunter Gaylor

著者: Hunter Gaylor
無料で聴く

このコンテンツについて

Let's get real about business, markets, and the bottom line. Join Hunter Gaylor in candid conversations with guests and callers as we break down what truly matters in the world of deals and investments. Tune in to "Markets Hunter" for straight talk, special guests, and deep dives into a variety of topics. Subscribe now and stay ahead of the game.Hunter Gaylor 政治・政府
エピソード
  • Innovating Wellness: An In-Depth Conversation with CEO Ilya Strashan of TransGlobal Assets Inc.
    2023/12/13

    We embark on a transformative journey into the heart of the health and wellness revolution with TransGlobal Assets Inc., symbol TMSH, leading the charge in diversified investments. Join us for an exclusive interview with the visionary CEO, Ilya Strashan, as we delve into the intricacies of one of their flagship subsidiaries, Better Health Sciences, Inc. 🚀 Revolutionizing Health and Wellness: Better Health Sciences, Inc. is not just a company; it's a force driving change in the health and wellness industries. With a steadfast commitment to staying at the forefront, Better Health Sciences specializes in developing cutting-edge technologies and solutions that redefine industry standards. CEO Ilya Strashan guides us through their mission to positively impact lives and contribute to the exponential growth of these vital sectors. 🌱 Cutting-Edge Technologies for a Better Tomorrow: In this in-depth interview, discover the latest advancements pioneered by Better Health Sciences. From groundbreaking products to innovative services, explore how their focus on technology is shaping the future of wellness. Ilya Strashan provides exclusive insights into the company's relentless pursuit of excellence and its dedication to enhancing the well-being of individuals worldwide. 🎙️ Exclusive CEO Perspective: Gain firsthand knowledge from CEO Ilya Strashan as he shares his vision for Better Health Sciences and TransGlobal Assets Inc. Learn about the strategies, values, and long-term goals that guide the company's decisions. This interview offers a rare glimpse into the mind of a leader driving positive change at the intersection of business and wellness. 📈 TransGlobal Assets Inc.: A Holistic Approach to Holdings: Beyond Better Health Sciences, understand how TransGlobal Assets Inc. strategically navigates the world of business holdings. Ilya Strashan discusses the company's diversified investment approach, positioning TransGlobal Assets as a key player in shaping the landscape of progressive, forward-thinking businesses. 🌟 A Gateway to the Future: Elevate your understanding of the health and wellness sectors as we explore the dynamic intersection of business, health, and technology. This interview is your gateway to the future of wellness, offering valuable insights for professionals, enthusiasts, and anyone passionate about the transformative power of innovation. 🔍 Stay Ahead of the Curve: Join us for this enlightening conversation that transcends industries. Stay ahead of the curve with TransGlobal Assets Inc.'s commitment to innovation and progress. Don't miss this exclusive interview; your journey towards a healthier and more advanced future starts here! https://betterhealthsciences.ca#TransGlobalAssets #BetterHealthSciences #WellnessInnovation #BusinessHoldings #HealthTechRevolution #CEOInterview #IndustryInnovations #FutureofWellness #CuttingEdgeTechnologies #PositiveImpact

    続きを読む 一部表示
    19 分
  • In-depth market coverage of $PETV Q4
    2023/10/10

    The Company’s first product that implemented the Biomatrix Particulate Technology, SPRYNG™ with OsteoCushion™ Technology, is an intra-articular injectable veterinary medical device consisting of sterilized, extra-cellular matrix microparticles; SPRYNG microparticles perform in the joint as wet, slippery micro-cushions used in the management of lameness and other joint related afflictions, such as osteoarthritis. https://www.petvivo.com/news-1/petviv... “Our biocompatible particulate technology and the claims to be issued in this patent application provides extremely comprehensive coverage. This patent increases the scope of our patent claims thereby expanding our competitive advantage in the commercialization of products used in the treatment of humans and companion animals,” stated PetVivo Chief Executive Officer, John Lai. https://www.petvivo.com/abouthttps://... https://www.petvivocares.org/ ****** The views expressed in Markets Hunter's content, productions, or other investor relations materials and presentations may be subject to change. Neither Markets Hunter nor any of its data or content providers shall be held responsible for any errors or delays in the content, or for any actions taken based on the information provided. All data and information is intended to be used for informational or entertainment purposes only. On occasion, we enter into contracts with third parties or publicly traded companies and receive financial remuneration in exchange for disseminating information and opinions regarding the company and the stock market such as this video. Markets Hunter is not a licensed broker-dealer or registered investment advisor. The content and productions of Markets Hunter are sourced from reliable data sources, though accuracy and completeness are not guaranteed. Consequently, the information should not be seen as tailored advice to any individual investor's specific needs. Markets Hunter.com is devoted to furnishing our readers with beneficial insights into publicly traded companies.

    続きを読む 一部表示
    19 分
  • Pet Health AI the future of Petvivo is Strong
    2023/08/30

    The Company’s first product that implemented the Biomatrix Particulate Technology, SPRYNG™ with OsteoCushion™ Technology, is an intra-articular injectable veterinary medical device consisting of sterilized, extra-cellular matrix microparticles; SPRYNG microparticles perform in the joint as wet, slippery micro-cushions used in the management of lameness and other joint related afflictions, such as osteoarthritis. https://www.petvivo.com/news-1/petviv... “Our biocompatible particulate technology and the claims to be issued in this patent application provides extremely comprehensive coverage. This patent increases the scope of our patent claims thereby expanding our competitive advantage in the commercialization of products used in the treatment of humans and companion animals,” stated PetVivo Chief Executive Officer, John Lai. https://www.petvivo.com/abouthttps://twitter.com/petvivo https://www.petvivocares.org/ ****** The views expressed in Markets Hunter's content, productions, or other investor relations materials and presentations may be subject to change. Neither Markets Hunter nor any of its data or content providers shall be held responsible for any errors or delays in the content, or for any actions taken based on the information provided. All data and information is intended to be used for informational or entertainment purposes only. On occasion, we enter into contracts with third parties or publicly traded companies and receive financial remuneration in exchange for disseminating information and opinions regarding the company and the stock market such as this video. Markets Hunter is not a licensed broker-dealer or registered investment advisor. The content and productions of Markets Hunter are sourced from reliable data sources, though accuracy and completeness are not guaranteed. Consequently, the information should not be seen as tailored advice to any individual investor's specific needs. Markets Hunter.com is devoted to furnishing our readers with beneficial insights into publicly traded companies.

    続きを読む 一部表示
    19 分

Markets Hunter - With Hunter Gaylorに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。